ClinicalTrials.gov
ClinicalTrials.gov Menu

Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00229307
Recruitment Status : Completed
First Posted : September 29, 2005
Last Update Posted : January 29, 2013
Sponsor:
Information provided by (Responsible Party):
Sheba Medical Center

Brief Summary:
Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment

Condition or disease Intervention/treatment Phase
PTSD Behavioral: Prolonged Exposure (PE) therapy Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 39 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : December 2005
Actual Primary Completion Date : December 2010
Actual Study Completion Date : December 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: 1 Behavioral: Prolonged Exposure (PE) therapy
20 minutes exposure
Active Comparator: 2 Behavioral: Prolonged Exposure (PE) therapy
40 minutes exposure



Primary Outcome Measures :
  1. PSS-i [ Time Frame: 15 weeks and 1-year follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PTSD

Exclusion Criteria:

  • Psychotic symptoms
  • Dissociation
  • Drug or Alcohol dependence

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00229307


Locations
Israel
Chaim Sheba Medical Center
Ramat-Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Study Chair: Nitza Nacasch, MD Sheba Medical Center
Principal Investigator: Joseph Zohar, MD Sheba Medical Center

Responsible Party: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00229307     History of Changes
Other Study ID Numbers: SHEBA-05-3709-JZ-CTIL
First Posted: September 29, 2005    Key Record Dates
Last Update Posted: January 29, 2013
Last Verified: January 2013

Keywords provided by Sheba Medical Center:
Post traumatic stress disorder

Additional relevant MeSH terms:
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Trauma and Stressor Related Disorders
Mental Disorders